Oridion Systems
This article was originally published in The Gray Sheet
Executive Summary
FDA clears SmartCapnoLine O2 capnography device for use in sedated, non-intubated patients to detect potentially fatal adverse events that can occur during sedation including apnea, ventilatory depression and airway obstruction. The product is in compliance with updated 2001 Joint Commission on Accreditation of Healthcare Organizations standards that call for monitoring ventilation in patients...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.